Bullish Options Activity in Teva Pharma (TEVA) Continues -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Merck (MRK) Wins Bid to Revive NuvaRing Patent Case Against Teva (TEVA) - Bloomberg
October 19, 2017 10:18 AM EDTMerck (NYSE: MRK) won a bid to revive a NuvaRing patent case against Teva Pharma (NYSE: TEVA), according to Bloomberg. A federal judge erred in ruling the patent for vaginal ring is invalid, said the U.S. Court of Appeals for the Federal Circuit in an opinion.
... More